Answers are grounded in this paper and cite their sources.
This analysis optimizes graft outcomes in HIV-positive patients receiving antiretroviral therapy, suggesting improved dosing strategies.
Optimizing tacrolimus exposure-rather than HIV status itself-is central to transplant outcomes in PLWH. Integrating ART-informed dosing, formulation flexibility, and advanced TDM strategies may reduce variability, improve graft outcomes, and inform future guideline development for this expanding transplant population.
No takes yet. Share an insight, caveat, or question.
Uraiwan Akanit (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: